PERMANENT, BIOLOGICALLY AND PHYSIOLOGICALLY BIOCOMPATIBLE, BIOACTIVE, BIOINTEGRATABLE, CONDUCTIVE, TISSUE-INDUCTIVE MEDICAL-VETERINARY DEVICES, PROCESS, PRODUCTION, COMPOSITES, AND SYSTEM FOR FIXING, REPAIR, RECONSTRUCTION, REMODELLING AND INTRA-, SUPRA-TISSUE AND/OR TOTAL PLASTIES
Where the main elements of the composites used in the manufacture are nanostructured phosphocalcic materials, mainly the HA/TCP biphasic, micro, macro porous bioceramics, as per patent PI 9104220-8, and PI 0602372-0 A2, "Process for obtaining bioceramic material and grafting morphogenetic bone protein" and "Process for the preparation of bioceramic and biodegradable polymer composites, containing antibiotics and angiotensin (1-7)", with the aforementioned devices being a new cutting edge development and a new state of the art of the object described in those patents, introducing bigger advantages, having conducting and inducing properties to be used in the tissue neoformation, reconstruction, modeling, plasties, maintenance of anatomic spaces, articular, inter- and extrabody reconstructions on current ones, being fully biointegratable, with no need to be removed following the implant, due to their composition along with mixing natural and/or synthetic polymeric substances, and/or calcium phosphate cementing substances, whether or not reabsorbable, with synergy of said advantages, eliminating the disadavantages, given the diverse formats for presentation, composition, architectural physical structures, porosities, plasticity, mechanical resistances, flexibility, mobility, modelability, whether specific or not, being an integral part of the morphogenetic protein due to their capacity to withstand both osteogenesis and chondrogenesis in relation to muscle skeletal tissues, being characterized by implantable prosthetic devices, definitive reconstructers, with no need to be removed by virtue of, but not limiting to, their properties of incorporation, biocompatibility, biointegration, interfaces bioactivity, easiness of application, logistics, storage, transport and better cost-benefit and risk-benefit ratio, and total possibility of being universalized, as they can be formed intra- and extrabody, produced in series or in a customized manner aimed at perfect adaptation an
